Error: Could not add to watchlist. X

Bellevue Funds Lux - BB Adamant Biotech

+ Watchlist
M0U2:GR
Frankfurt
312.99
EUR
8.09
2.65%
As of 4:57 AM EST on 2/10/2016.
Open
308.55
Day Range
306.50 - 312.99
Previous Close
304.90
52Wk Range
304.90 - 542.75
1 Yr Return
-26.36%
YTD Return
-30.61%
Open
308.55
Day Range
306.50 - 312.99
Volume
0
Previous Close
304.90
52Wk Range
304.90 - 542.75
1 Yr Return
-27.37%
YTD Return
-30.61%
NAV (on -)
-
Total Assets (m USD) (on 02/08/2016)
63.284
Inception Date
03/31/2009
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
CHRISTIAN LACH
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
2.40%
3 Mo Return
-31.33%
3 Yr Return
23.13%
5 Yr Return
20.49%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 24.20 k 7.41 m 8.30
Celgene Corp 60.00 k 7.19 m 8.04
Regeneron Pharmaceuticals Inc 13.00 k 7.06 m 7.90
Gilead Sciences Inc 62.00 k 6.27 m 7.02
Amgen Inc 38.00 k 6.17 m 6.91
Mylan NV 70.00 k 3.78 m 4.24
Illumina Inc 19.30 k 3.70 m 4.15
Alexion Pharmaceuticals Inc 18.40 k 3.51 m 3.93
Vertex Pharmaceuticals Inc 25.00 k 3.15 m 3.52
Incyte Corp 29.00 k 3.15 m 3.52
Profile
Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.
ADDRESS
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
PHONE
41-44-267-67-00